Raymond James Financial Inc Humacyte, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 74,698 shares of HUMA stock, worth $318,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,698Holding current value
$318,213% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
35.8MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$21.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$20.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.69 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.4 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $439M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...